Heartflow Inc (HTFL) SEC 13F Holdings (Q2 2026): Institutional Buyers & Sellers

HTFL ranks #3060 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

HTFL is a top-conviction position for Bain Capital Life Sciences Investors, LLC — at 14.7% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

Wealth Enhancement Advisory Services, LLC has added to its HTFL position for two straight quarters, increasing it by $3.9M to reach $7.2M today.

Essential Partners LLC has trimmed its HTFL position for two straight quarters, cutting it by $47.6K while still holding $9.4K.

HTFL is up 4.4% today, and institutions have been net buyers of $396.6M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

HTFL reported a net loss of $118.4M over the trailing twelve months.

• Not yet profitable — net loss of $118.4M over the trailing twelve months
• Revenue grew 42.8% year over year
• Net income declined year over year, from -$93.7M to -$118.4M
• Operating cash flow was negative, using $54.0M in cash
• Current ratio of 5.20x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.20x equity — within a conventional range